Indeed, it was demonstrated that binding and neutralizing antibody responses decay over the first four months post-infection with a similar decline in Spike-specific CD4+ and circulating T follicular helper frequencies in a cohort of patients who recovered from mild/moderate COVID-19 [26]. The gene discussed is CD4; the disease is COVID-19.